A Unique Radiological Correlate of CSF1R Mutation

Dubey, Souvik; Das, Shambaditya; Pandit, Alak; Chakraborty, ArkaPrava; Bhattacharya, Sougata

doi:10.4103/aian.aian_300_22

Cited by 1 publication

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All three pathogenic variants of TREM2 , TYROBP , and CSF1R reported are novel, and TREM2 (without osseous changes) and TYROBP in dementia are described for the first time from a single centre in the Indian subcontinent. There are a few case reports of CSF1R reported in the literature from India, but there is no published literature where CSF1R is associated with an atypical AD phenotype so far [28‒32].…”

Section: Discussionmentioning

confidence: 99%

“…This reported case series of 3 patients of CSF1R -related leukoencephalopathy or ALSP highlights the variability in the phenotypic presentation of CSF1R mutation: cases 3 and 5 presented with FTD and case 4 presented as atypical AD. Although a few Indian reports of dementia patients with CSF1R mutation are published, the genetic novelty in case 3 was pathogenic intronic 14 mutation and the clinical novelty was that aphasia was prominent in the course of illness [ 28 , 29 , 30 , 31 , 32 , 57 , 58 , 59 , 60 ]. Aphasia is described only in 19% of the series in literature [ 27 , 57 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Primary microgliopathy presenting as degenerative dementias: A case series of novel gene mutations from India

Ramakrishnan,

Arshad,

et al. 2024

Dement Geriatr Cogn Disord Extra

View full text Add to dashboard Cite

Introduction Microglia exert a crucial role in homeostasis of white matter integrity and several studies highlight the role of microglial dysfunctions in neurodegeneration. Primary microgliopathy are disorders where the pathogenic abnormality of the microglia causes white matter disorder and leads to a neuropsychiatric diseases. Triggering Receptor Expressed on Myeloid Cells (TREM2), TYRO protein tyrosine kinase binding protein (TYROBP), Colony-stimulating factor 1 receptor (CSF1R) are genes implicated in primary microgliopathy. Clinical manifestations of primary microgliopathy are myriad ranging from neuropsychiatric syndrome, motor disability, gait dysfunction, ataxia, pure dementia, frontotemporal dementia, Alzheimer dementia and so on. It becomes imperative to establish diagnosis of microgliopathy masquerading as degenerative dementia, especially with promising therapies on horizon for the same. We aim to describe a case series of subjects with dementia harboring novel genes of primary microgliopathy, along with their clinical, neuropsychological, and cognitive profile and radiological patterns. Methods: The prospective study was conducted in a university referral hospital in South India, as a part of an ongoing clinic-genetic research on Dementia subjects and was approved by the institutional ethics committee. All patients underwent detailed assessment including socio demographic profile, clinical and cognitive assessment, pedigree analysis and comprehensive neurological examination. Subjects consenting for blood sampling underwent genetic testing by Whole exome sequencing (WES). Results: 100 patients of dementia underwent genetic analysis using whole exome sequencing and three pathogenic variants, one each of TREM2, TYROBP and CSF1R and two variants of uncertain significance in CSF1R were identified as cause of primary microgliopathy .TREM 2 and TYROBP presented as frontotemporal syndrome whereas CSF1R presented as frontotemporal syndrome and Alzheimer dementia. Conclusion :WES has widened the spectrum of underlying neuropathology of degenerative dementias and diagnosing primary microglial dysfunction with emerging therapeutic options is of paramount importance. Cases of primary microgliopathy due to Novel mutations in TREM2, TYROBP and CSF1R with phenotype of degenerative dementia are being first time reported from Indian cohort. Our study enriches the spectrum of genetic variants implicated in degenerative dementia, and provides the basis for exploring complex molecular mechanisms like microglial dysfunction, as underlying cause for neurodegeneration.

show abstract

Section: Discussionmentioning

confidence: 99%